Compare GALT & AEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GALT | AEC |
|---|---|---|
| Founded | 2000 | 1989 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.7M | 165.3M |
| IPO Year | N/A | N/A |
| Metric | GALT | AEC |
|---|---|---|
| Price | $2.84 | $6.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 322.0K | 147.4K |
| Earning Date | 11-14-2025 | 05-01-2015 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.12 | $2.55 |
| 52 Week High | $7.13 | $12.49 |
| Indicator | GALT | AEC |
|---|---|---|
| Relative Strength Index (RSI) | 37.78 | 48.32 |
| Support Level | $2.61 | $6.03 |
| Resistance Level | $3.30 | $7.07 |
| Average True Range (ATR) | 0.23 | 0.86 |
| MACD | 0.04 | -0.25 |
| Stochastic Oscillator | 21.05 | 22.57 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Anfield Energy Inc is a mineral exploration and development company. This company focuses on uranium and vanadium development and near-term production. The exploration project of the company includes Shootaring Canyon Mill and Velvet-Wood and Slick Rock Uranium Project from Uranium One. The company's geographical segments are Canada and the United States.